Stem cell therapy has become one of the most discussed and most misunderstood areas of regenerative medicine. The phrase covers a broad set of protocols, not a single product, and the differences between them matter for both safety and outcomes. This post outlines what stem cell therapy is, how it is used in clinical practice today, and what to ask before pursuing it.
At its core, stem cell therapy uses cells with the ability to develop into specialized tissue to support the body’s natural repair processes. In orthopedic and regenerative medicine, the most common sources are bone marrow and adipose tissue from the patient. Other protocols use perinatal tissues sourced through licensed providers under specific regulatory pathways.
Conditions most often discussed in connection with stem cell therapy include joint pain from osteoarthritis, tendon and ligament injuries, and certain musculoskeletal conditions where surgery has been recommended but not yet performed.
The most important conversation to have before any cellular therapy is regulatory and clinical. Patients should ask which cells are being used, where they were sourced, how they are processed, and what the FDA status of the protocol is for the specific indication being treated. They should also ask what the realistic range of outcomes looks like and what the alternatives are.
At VitalStem Institute, cellular protocols are evaluated patient by patient. The clinical team reviews diagnostic imaging, history, and goals before recommending whether a cellular approach is appropriate, and discusses regulatory and clinical context openly during consultation.
